FDA approves remdesivir, first treatment for COVID-19
October 22, 2020
The FDA also issued a new EUA for remdesivir allowing treatment of hospitalized pediatric patients younger than 12 weighing at least 3.5 kg.
FDA expands remdesivir use for all COVID-19 hospitalized patients
August 31, 2020
An EUA of remdesivir issued in May allowed the drug to be used only for patients with severe COVID-19, specifically, COVID-19 patients with low blood oxygen levels or who need oxygen therapy or mechanical ventilation.